Literature DB >> 27942948

Potentially inappropriate prescribing in a population of frail elderly people.

Isabelle Récoché1, Cécile Lebaudy2, Charlène Cool3,4, Sandrine Sourdet4,5, Antoine Piau5, Maryse Lapeyre-Mestre4,6, Bruno Vellas4,5, Philippe Cestac3,4.   

Abstract

Background Frailty is a clinical syndrome highly predictive of functional decline after a stress or a medical event, such as adverse drug events. Objective To describe the prevalence of potentially inappropriate prescribing in a population of frail elderly patients. Setting Geriatric day hospital for assessment of frailty and prevention of disability, Toulouse, France. Method A cross-sectional study performed from January to April 2014. Two pharmacists retrospectively analyzed the prescriptions of elderly patients who were sent to the day hospital to assess their frailty and to be given a personalized plan of care and prevention. Potentially inappropriate prescribing was defined by combining explicit criteria: Laroche list, screening tool of older people's prescriptions, and screening tool to alert to right treatment with an implicit method (drug utilization review for each medication). Prescriptions' optimizations were then suggested to the geriatricians of the day hospital and classified according to criteria defined by the French Society of Clinical Pharmacy. Main outcome measure Prevalence of potentially inappropriate prescribing. Results Among the 229 patients included, 71.2% had potentially inappropriate prescribing. 76 patients (33.2%) had at least one drug without any valid indication. 51 (22.3%) had at least one drug with an unfavorable benefit-to-risk ratio according to their clinical and biological data, 42 (18.3%) according to the Laroche list and 38 (16.6%) had at least one drug with questionable efficacy. Conclusion Our work shows that the incidence of PIP is high in the frail elderly and that, in most cases, it could be avoided with an adequate and regular reassessment of the prescriptions. In future, prescription optimization will be integrated into the personalized medical care plan to further prevent drug-related disability.

Entities:  

Keywords:  Adverse drug event; Drug therapy; Frail elderly; France; Inappropriate prescribing

Mesh:

Year:  2016        PMID: 27942948     DOI: 10.1007/s11096-016-0406-2

Source DB:  PubMed          Journal:  Int J Clin Pharm


  27 in total

1.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

Authors:  S KATZ; A B FORD; R W MOSKOWITZ; B A JACKSON; M W JAFFE
Journal:  JAMA       Date:  1963-09-21       Impact factor: 56.272

Review 2.  Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care.

Authors:  Linda P Fried; Luigi Ferrucci; Jonathan Darer; Jeff D Williamson; Gerard Anderson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2004-03       Impact factor: 6.053

3.  American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2015-10-08       Impact factor: 5.562

Review 4.  Polypharmacy and the geriatric patient.

Authors:  Bryan D Hayes; Wendy Klein-Schwartz; Fermin Barrueto
Journal:  Clin Geriatr Med       Date:  2007-05       Impact factor: 3.076

5.  Prevalence and impact of fall-risk-increasing drugs, polypharmacy, and drug-drug interactions in robust versus frail hospitalised falls patients: a prospective cohort study.

Authors:  Alexander Bennett; Danijela Gnjidic; Mark Gillett; Peter Carroll; Slade Matthews; Kristina Johnell; Johan Fastbom; Sarah Hilmer
Journal:  Drugs Aging       Date:  2014-03       Impact factor: 3.923

Review 6.  Adverse effects of long-term proton pump inhibitor therapy.

Authors:  Edward Sheen; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2011-03-02       Impact factor: 3.199

7.  High-risk prescribing and incidence of frailty among older community-dwelling men.

Authors:  D Gnjidic; S N Hilmer; F M Blyth; V Naganathan; R G Cumming; D J Handelsman; A J McLachlan; D R Abernethy; E Banks; D G Le Couteur
Journal:  Clin Pharmacol Ther       Date:  2012-02-01       Impact factor: 6.875

8.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

9.  Frailty consensus: a call to action.

Authors:  John E Morley; Bruno Vellas; G Abellan van Kan; Stefan D Anker; Juergen M Bauer; Roberto Bernabei; Matteo Cesari; W C Chumlea; Wolfram Doehner; Jonathan Evans; Linda P Fried; Jack M Guralnik; Paul R Katz; Theodore K Malmstrom; Roger J McCarter; Luis M Gutierrez Robledo; Ken Rockwood; Stephan von Haehling; Maurits F Vandewoude; Jeremy Walston
Journal:  J Am Med Dir Assoc       Date:  2013-06       Impact factor: 4.669

10.  Looking for frailty in community-dwelling older persons: the Gérontopôle Frailty Screening Tool (GFST).

Authors:  B Vellas; L Balardy; S Gillette-Guyonnet; G Abellan Van Kan; A Ghisolfi-Marque; J Subra; S Bismuth; S Oustric; M Cesari
Journal:  J Nutr Health Aging       Date:  2013-07       Impact factor: 4.075

View more
  11 in total

1.  Reducing potentially inappropriate drug prescribing in nursing home residents: effectiveness of a geriatric intervention.

Authors:  Charlène Cool; Philippe Cestac; Cécile McCambridge; Laure Rouch; Philipe de Souto Barreto; Yves Rolland; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2018-05-14       Impact factor: 4.335

2.  Hospitalization Drug Regimen Changes in Geriatric Patients and Adherence to Modifications by General Practitioners in Primary Care.

Authors:  L Rouch; F Farbos; C Cool; C McCambridge; C Hein; S Elmalem; Y Rolland; B Vellas; P Cestac
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

3.  Drug Prescription Including Interactions with Anticancer Treatments in the Elderly: A Global Approach.

Authors:  M-E Rougé Bugat; M Bourgouin; S Gérard; S Lozano; D Brechemier; P Cestac; C Cool; L Balardy
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

4.  Impact of collaborative pharmaceutical care on in-patients' medication safety: study protocol for a stepped wedge cluster randomized trial (MEDREV study).

Authors:  Géraldine Leguelinel-Blache; Christel Castelli; Clarisse Roux-Marson; Sophie Bouvet; Sandrine Andrieu; Philippe Cestac; Rémy Collomp; Paul Landais; Bertrice Loulière; Christelle Mouchoux; Rémi Varin; Benoit Allenet; Pierrick Bedouch; Jean-Marie Kinowski
Journal:  Trials       Date:  2018-01-08       Impact factor: 2.279

5.  Evaluation of pharmacist interventions and commonly used medications in the geriatric ward of a teaching hospital in Turkey: a retrospective study.

Authors:  Elif Ertuna; Mehmet Zuhuri Arun; Seval Ay; Fatma Özge Kayhan Koçak; Bahattin Gökdemir; Gül İspirli
Journal:  Clin Interv Aging       Date:  2019-03-21       Impact factor: 4.458

6.  Impact of a Pharmacist-included Mobile Geriatrics team intervention on potentially inappropriate drug prescribing: protocol for a prospective feasibility study (PharMoG study).

Authors:  Arnaud Pagès; Christel Roland; Soraya Qassemi; Anne-Bahia Abdeljalil; Mathieu Houles; Marjolaine Romain; Olivier Toulza; Audrey Belloc; Cécile McCambridge; Thierry Voisin; Philippe Cestac; Blandine Juillard-Condat
Journal:  BMJ Open       Date:  2020-12-02       Impact factor: 2.692

Review 7.  Interventions to improve medicines optimisation in frail older patients in secondary and acute care settings: a systematic review of randomised controlled trials and non-randomised studies.

Authors:  Dima Saeed; Gillian Carter; Carole Parsons
Journal:  Int J Clin Pharm       Date:  2021-11-20

8.  A pilot study to identify elderly patients with cognitive impairment for clinical pharmacist polypharmacy review in General Practice.

Authors:  Pamela Mills; Katie MacLure
Journal:  Explor Res Clin Soc Pharm       Date:  2021-08-26

9.  Improving individualized prescription in patients with multimorbidity through medication review.

Authors:  Núria Molist-Brunet; Daniel Sevilla-Sánchez; Emma Puigoriol-Juvanteny; Matilde Barneto-Soto; Javier González-Bueno; Joan Espaulella-Panicot
Journal:  BMC Geriatr       Date:  2022-05-12       Impact factor: 4.070

10.  Individualized Medication Review in Older People with Multimorbidity: A Comparative Analysis between Patients Living at Home and in a Nursing Home.

Authors:  Núria Molist-Brunet; Daniel Sevilla-Sánchez; Emma Puigoriol-Juvanteny; Lorena Bajo-Peñas; Immaculada Cantizano-Baldo; Laia Cabanas-Collell; Joan Espaulella-Panicot
Journal:  Int J Environ Res Public Health       Date:  2022-03-14       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.